Kanta Subbarao

InstitutionLaboratory of Infectious Diseases
AddressBethesda
Maryland
United States
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 30 Covid-19 publications, with a maximum of 5 publications in May 2021
    All Publications
    Bar chart showing 236 publications over 27 distinct years, with a maximum of 20 publications in 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Lopez E, Haycroft ER, Adair A, Mordant FL, O'Neill MT, Pymm P, Redmond SJ, Lee WS, Gherardin NA, Wheatley AK, Juno JA, Selva KJ, Davis SK, Grimley SL, Harty L, Purcell DF, Subbarao K, Godfrey DI, Kent SJ, Tham WH, Chung AW. Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay. JCI Insight. 2021 08 23; 6(16). PMID: 34251356.
      Citations: 6     Fields:    Translation:Humans
    2. Lynch SA, Subbarao K, Mahanty S, Barber BE, Roulis EV, van der Hoek L, McCarthy JS, Spann KM. Prevalence of Neutralising Antibodies to HCoV-NL63 in Healthy Adults in Australia. Viruses. 2021 08 16; 13(8). PMID: 34452482.
      Citations:    Fields:    Translation:HumansCells
    3. Subbarao K. The success of SARS-CoV-2 vaccines and challenges ahead. Cell Host Microbe. 2021 07 14; 29(7):1111-1123. PMID: 34265245.
      Citations: 4     Fields:    Translation:HumansAnimalsPHPublic Health
    4. Calisher CH, Carroll D, Colwell R, Corley RB, Daszak P, Drosten C, Enjuanes L, Farrar J, Field H, Golding J, Gorbalenya AE, Haagmans B, Hughes JM, Keusch GT, Lam SK, Lubroth J, Mackenzie JS, Madoff L, Mazet JK, Perlman SM, Poon L, Saif L, Subbarao K, Turner M. Science, not speculation, is essential to determine how SARS-CoV-2 reached humans. Lancet. 2021 07 17; 398(10296):209-211. PMID: 34237296.
      Citations: 3     Fields:    Translation:Humans
    5. Krause PR, Fleming TR, Longini IM, Peto R, Briand S, Heymann DL, Beral V, Snape MD, Rees H, Ropero AM, Balicer RD, Cramer JP, Muñoz-Fontela C, Gruber M, Gaspar R, Singh JA, Subbarao K, Van Kerkhove MD, Swaminathan S, Ryan MJ, Henao-Restrepo AM. SARS-CoV-2 Variants and Vaccines. N Engl J Med. 2021 Jul 08; 385(2):179-186. PMID: 34161052.
      Citations: 37     Fields:    Translation:Humans
    6. Levine MM, Abdullah S, Arabi YM, Darko DM, Durbin AP, Estrada V, Jamrozik E, Kremsner PG, Lagos R, Pitisuttithum P, Plotkin SA, Sauerwein R, Shi SL, Sommerfelt H, Subbarao K, Treanor JJ, Vrati S, King D, Balasingam S, Weller C, Aguilar AO, Cassetti MC, Krause PR, Restrepo AMH. Viewpoint of a WHO Advisory Group Tasked to Consider Establishing a Closely-monitored Challenge Model of Coronavirus Disease 2019 (COVID-19) in Healthy Volunteers. Clin Infect Dis. 2021 06 01; 72(11):2035-2041. PMID: 32857836.
      Citations: 2     Fields:    Translation:Humans
    7. Toh ZQ, Higgins RA, Do LAH, Rautenbacher K, Mordant FL, Subbarao K, Dohle K, Nguyen J, Steer AC, Tosif S, Crawford NW, Mulholland K, Licciardi PV. Persistence of SARS-CoV-2-Specific IgG in Children 6 Months After Infection, Australia. Emerg Infect Dis. 2021; 27(8):2233-2235. PMID: 34016252.
      Citations: 2     Fields:    Translation:Humans
    8. Khoury DS, Cromer D, Reynaldi A, Schlub TE, Wheatley AK, Juno JA, Subbarao K, Kent SJ, Triccas JA, Davenport MP. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat Med. 2021 07; 27(7):1205-1211. PMID: 34002089.
      Citations: 298     Fields:    Translation:Humans
    9. Pymm P, Adair A, Chan LJ, Cooney JP, Mordant FL, Allison CC, Lopez E, Haycroft ER, O'Neill MT, Tan LL, Dietrich MH, Drew D, Doerflinger M, Dengler MA, Scott NE, Wheatley AK, Gherardin NA, Venugopal H, Cromer D, Davenport MP, Pickering R, Godfrey DI, Purcell DFJ, Kent SJ, Chung AW, Subbarao K, Pellegrini M, Glukhova A, Tham WH. Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice. Proc Natl Acad Sci U S A. 2021 05 11; 118(19). PMID: 33893175.
      Citations: 16     Fields:    Translation:HumansAnimals
    10. Audsley JM, Holmes NE, Mordant FL, Douros C, Zufan SE, Nguyen THO, Kedzierski L, Rowntree LC, Hensen L, Subbarao K, Kedzierska K, Nicholson S, Sherry N, Thevarajan I, Tran T, Druce J. Temporal differences in culturable severe acute respiratory coronavirus virus 2 (SARS-CoV-2) from the respiratory and gastrointestinal tracts in a patient with moderate coronavirus disease 2019 (COVID-19). Infect Control Hosp Epidemiol. 2021 May 10; 1-3. PMID: 33966675.
      Citations:    Fields:    
    11. Nicholson S, Karapanagiotidis T, Khvorov A, Douros C, Mordant F, Bond K, Druce J, Williamson DA, Purcell D, Lewin SR, Sullivan S, Subbarao K, Catton M. Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance. Open Forum Infect Dis. 2021 Jul; 8(7):ofab239. PMID: 34258311.
      Citations: 1     
    12. Chang JJ, Rawlinson D, Pitt ME, Taiaroa G, Gleeson J, Zhou C, Mordant FL, De Paoli-Iseppi R, Caly L, Purcell DFJ, Stinear TP, Londrigan SL, Clark MB, Williamson DA, Subbarao K, Coin LJM. Transcriptional and epi-transcriptional dynamics of SARS-CoV-2 during cellular infection. Cell Rep. 2021 05 11; 35(6):109108. PMID: 33961822.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    13. Chappell KJ, Mordant FL, Li Z, Wijesundara DK, Ellenberg P, Lackenby JA, Cheung STM, Modhiran N, Avumegah MS, Henderson CL, Hoger K, Griffin P, Bennet J, Hensen L, Zhang W, Nguyen THO, Marrero-Hernandez S, Selva KJ, Chung AW, Tran MH, Tapley P, Barnes J, Reading PC, Nicholson S, Corby S, Holgate T, Wines BD, Hogarth PM, Kedzierska K, Purcell DFJ, Ranasinghe C, Subbarao K, Watterson D, Young PR, Munro TP. Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial. Lancet Infect Dis. 2021 10; 21(10):1383-1394. PMID: 33887208.
      Citations: 12     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    14. Citations: 5     
    15. Citations: 15     Fields:    Translation:HumansAnimalsCells
    16. Tan HX, Juno JA, Lee WS, Barber-Axthelm I, Kelly HG, Wragg KM, Esterbauer R, Amarasena T, Mordant FL, Subbarao K, Kent SJ, Wheatley AK. Immunogenicity of prime-boost protein subunit vaccine strategies against SARS-CoV-2 in mice and macaques. Nat Commun. 2021 03 03; 12(1):1403. PMID: 33658497.
      Citations: 14     Fields:    Translation:HumansAnimalsCells
    17. Rowntree LC, Chua BY, Nicholson S, Koutsakos M, Hensen L, Douros C, Selva K, Mordant FL, Wong CY, Habel JR, Zhang W, Jia X, Allen L, Doolan DL, Jackson DC, Wheatley AK, Kent SJ, Amanat F, Krammer F, Subbarao K, Cheng AC, Chung AW, Catton M, Nguyen TH, van de Sandt CE, Kedzierska K. Robust correlations across six SARS-CoV-2 serology assays detecting distinct antibody features. Clin Transl Immunology. 2021; 10(3):e1258. PMID: 33680466.
      Citations: 5     
    18. Cunningham AL, McIntyre P, Subbarao K, Booy R, Levin MJ. Vaccines for older adults. BMJ. 2021 02 22; 372:n188. PMID: 33619170.
      Citations: 4     Fields:    Translation:HumansAnimals
    19. Wheatley AK, Juno JA, Wang JJ, Selva KJ, Reynaldi A, Tan HX, Lee WS, Wragg KM, Kelly HG, Esterbauer R, Davis SK, Kent HE, Mordant FL, Schlub TE, Gordon DL, Khoury DS, Subbarao K, Cromer D, Gordon TP, Chung AW, Davenport MP, Kent SJ. Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19. Nat Commun. 2021 02 19; 12(1):1162. PMID: 33608522.
      Citations: 54     Fields:    Translation:HumansCells
    20. Citations: 13     
    21. Tosif S, Neeland MR, Sutton P, Licciardi PV, Sarkar S, Selva KJ, Do LAH, Donato C, Quan Toh Z, Higgins R, Van de Sandt C, Lemke MM, Lee CY, Shoffner SK, Flanagan KL, Arnold KB, Mordant FL, Mulholland K, Bines J, Dohle K, Pellicci DG, Curtis N, McNab S, Steer A, Steer A, Saffery R, Subbarao K, Chung AW, Kedzierska K, Burgner DP, Crawford NW. Immune responses to SARS-CoV-2 in three children of parents with symptomatic COVID-19. Nat Commun. 2020 11 11; 11(1):5703. PMID: 33177504.
      Citations: 30     Fields:    Translation:HumansCellsPHPublic Health
    22. Khoury DS, Wheatley AK, Ramuta MD, Reynaldi A, Cromer D, Subbarao K, O'Connor DH, Kent SJ, Davenport MP. Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models. Nat Rev Immunol. 2020 12; 20(12):727-738. PMID: 33139888.
      Citations: 24     Fields:    Translation:HumansAnimalsPHPublic Health
    23. Subbarao K. COVID-19 vaccines: time to talk about the uncertainties. Nature. 2020 10; 586(7830):475. PMID: 33082537.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    24. Subbarao K, Mordant F, Rudraraju R. Convalescent plasma treatment for COVID-19: Tempering expectations with the influenza experience. Eur J Immunol. 2020 10; 50(10):1447-1453. PMID: 32886952.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    25. Bond K, Nicholson S, Lim SM, Karapanagiotidis T, Williams E, Johnson D, Hoang T, Sia C, Purcell D, Mordant F, Lewin SR, Catton M, Subbarao K, Howden BP, Williamson DA. Evaluation of Serological Tests for SARS-CoV-2: Implications for Serology Testing in a Low-Prevalence Setting. J Infect Dis. 2020 09 14; 222(8):1280-1288. PMID: 32761124.
      Citations: 22     Fields:    Translation:HumansCellsPHPublic Health
    26. Juno JA, Tan HX, Lee WS, Reynaldi A, Kelly HG, Wragg K, Esterbauer R, Kent HE, Batten CJ, Mordant FL, Gherardin NA, Pymm P, Dietrich MH, Scott NE, Tham WH, Godfrey DI, Subbarao K, Davenport MP, Kent SJ, Wheatley AK. Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19. Nat Med. 2020 09; 26(9):1428-1434. PMID: 32661393.
      Citations: 129     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    27. Lambert PH, Ambrosino DM, Andersen SR, Baric RS, Black SB, Chen RT, Dekker CL, Didierlaurent AM, Graham BS, Martin SD, Molrine DC, Perlman S, Picard-Fraser PA, Pollard AJ, Qin C, Subbarao K, Cramer JP. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines. Vaccine. 2020 06 26; 38(31):4783-4791. PMID: 32507409.
      Citations: 39     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    28. Subbarao K, Mahanty S. Respiratory Virus Infections: Understanding COVID-19. Immunity. 2020 06 16; 52(6):905-909. PMID: 32497522.
      Citations: 57     Fields:    Translation:HumansCellsPHPublic Health
    29. Subbarao K. SARS-CoV-2: A New Song Recalls an Old Melody. Cell Host Microbe. 2020 05 13; 27(5):692-694. PMID: 32407706.
      Citations: 7     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    30. Calisher C, Carroll D, Colwell R, Corley RB, Daszak P, Drosten C, Enjuanes L, Farrar J, Field H, Golding J, Gorbalenya A, Haagmans B, Hughes JM, Karesh WB, Keusch GT, Lam SK, Lubroth J, Mackenzie JS, Madoff L, Mazet J, Palese P, Perlman S, Poon L, Roizman B, Saif L, Saif L, Subbarao K, Turner M. Statement in support of the scientists, public health professionals, and medical professionals of China combatting COVID-19. Lancet. 2020 03 07; 395(10226):e42-e43. PMID: 32087122.
      Citations: 54     Fields:    Translation:HumansCellsPHPublic Health
    31. Houser KV, Broadbent AJ, Gretebeck L, Vogel L, Lamirande EW, Sutton T, Bock KW, Minai M, Orandle M, Moore IN, Subbarao K. Enhanced inflammation in New Zealand white rabbits when MERS-CoV reinfection occurs in the absence of neutralizing antibody. PLoS Pathog. 2017 Aug; 13(8):e1006565. PMID: 28817732.
      Citations: 43     Fields:    Translation:AnimalsCells
    32. Zhao J, Alshukairi AN, Baharoon SA, Ahmed WA, Bokhari AA, Nehdi AM, Layqah LA, Alghamdi MG, Al Gethamy MM, Dada AM, Khalid I, Boujelal M, Al Johani SM, Vogel L, Subbarao K, Mangalam A, Wu C, Ten Eyck P, Perlman S, Zhao J. Recovery from the Middle East respiratory syndrome is associated with antibody and T-cell responses. Sci Immunol. 2017 Aug 04; 2(14). PMID: 28778905.
      Citations: 106     Fields:    
    33. Houser KV, Gretebeck L, Ying T, Wang Y, Vogel L, Lamirande EW, Bock KW, Moore IN, Dimitrov DS, Subbarao K. Prophylaxis With a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-Specific Human Monoclonal Antibody Protects Rabbits From MERS-CoV Infection. J Infect Dis. 2016 May 15; 213(10):1557-61. PMID: 26941283.
      Citations: 38     Fields:    Translation:HumansAnimalsCells
    34. Wang L, Shi W, Joyce MG, Modjarrad K, Zhang Y, Leung K, Lees CR, Zhou T, Yassine HM, Kanekiyo M, Yang ZY, Chen X, Becker MM, Freeman M, Vogel L, Johnson JC, Olinger G, Todd JP, Bagci U, Solomon J, Mollura DJ, Hensley L, Jahrling P, Denison MR, Rao SS, Subbarao K, Kwong PD, Mascola JR, Kong WP, Graham BS. Evaluation of candidate vaccine approaches for MERS-CoV. Nat Commun. 2015 Jul 28; 6:7712. PMID: 26218507.
      Citations: 138     Fields:    Translation:HumansAnimalsCells
    35. Gretebeck LM, Subbarao K. Animal models for SARS and MERS coronaviruses. Curr Opin Virol. 2015 Aug; 13:123-9. PMID: 26184451.
      Citations: 75     Fields:    Translation:HumansAnimalsCells
    36. Sutton TC, Subbarao K. Development of animal models against emerging coronaviruses: From SARS to MERS coronavirus. Virology. 2015 May; 479-480:247-58. PMID: 25791336.
      Citations: 47     Fields:    Translation:HumansAnimalsCells
    37. Jaume M, Yip MS, Kam YW, Cheung CY, Kien F, Roberts A, Li PH, Dutry I, Escriou N, Daeron M, Bruzzone R, Subbarao K, Peiris JS, Nal B, Altmeyer R. SARS CoV subunit vaccine: antibody-mediated neutralisation and enhancement. Hong Kong Med J. 2012 Feb; 18 Suppl 2:31-6. PMID: 22311359.
      Citations: 46     Fields:    Translation:HumansAnimalsCells
    38. Frieman M, Yount B, Agnihothram S, Page C, Donaldson E, Roberts A, Vogel L, Woodruff B, Scorpio D, Subbarao K, Baric RS. Molecular determinants of severe acute respiratory syndrome coronavirus pathogenesis and virulence in young and aged mouse models of human disease. J Virol. 2012 Jan; 86(2):884-97. PMID: 22072787.
      Citations: 70     Fields:    Translation:HumansAnimalsCells
    39. Roberts A, Lamirande EW, Vogel L, Baras B, Goossens G, Knott I, Chen J, Ward JM, Vassilev V, Subbarao K. Immunogenicity and protective efficacy in mice and hamsters of a ß-propiolactone inactivated whole virus SARS-CoV vaccine. Viral Immunol. 2010 Oct; 23(5):509-19. PMID: 20883165.
      Citations: 26     Fields:    Translation:AnimalsCellsPHPublic Health
    40. Frieman MB, Chen J, Morrison TE, Whitmore A, Funkhouser W, Ward JM, Lamirande EW, Roberts A, Heise M, Subbarao K, Baric RS. SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism. PLoS Pathog. 2010 Apr 08; 6(4):e1000849. PMID: 20386712.
      Citations: 84     Fields:    Translation:AnimalsCells
    41. Chen J, Lau YF, Lamirande EW, Paddock CD, Bartlett JH, Zaki SR, Subbarao K. Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection. J Virol. 2010 Feb; 84(3):1289-301. PMID: 19906920.
      Citations: 182     Fields:    Translation:AnimalsCells
    42. Freundt EC, Yu L, Goldsmith CS, Welsh S, Cheng A, Yount B, Liu W, Frieman MB, Buchholz UJ, Screaton GR, Lippincott-Schwartz J, Zaki SR, Xu XN, Baric RS, Subbarao K, Lenardo MJ. The open reading frame 3a protein of severe acute respiratory syndrome-associated coronavirus promotes membrane rearrangement and cell death. J Virol. 2010 Jan; 84(2):1097-109. PMID: 19889773.
      Citations: 44     Fields:    Translation:HumansAnimalsCells
    43. Baas T, Roberts A, Teal TH, Vogel L, Chen J, Tumpey TM, Katze MG, Subbarao K. Genomic analysis reveals age-dependent innate immune responses to severe acute respiratory syndrome coronavirus. J Virol. 2008 Oct; 82(19):9465-76. PMID: 18632870.
      Citations: 39     Fields:    Translation:AnimalsCells
    44. Lamirande EW, DeDiego ML, Roberts A, Jackson JP, Alvarez E, Sheahan T, Shieh WJ, Zaki SR, Baric R, Enjuanes L, Subbarao K. A live attenuated severe acute respiratory syndrome coronavirus is immunogenic and efficacious in golden Syrian hamsters. J Virol. 2008 Aug; 82(15):7721-4. PMID: 18463152.
      Citations: 67     Fields:    Translation:AnimalsCells
    45. Zhu Z, Chakraborti S, He Y, Roberts A, Sheahan T, Xiao X, Hensley LE, Prabakaran P, Rockx B, Sidorov IA, Corti D, Vogel L, Feng Y, Kim JO, Wang LF, Baric R, Lanzavecchia A, Curtis KM, Nabel GJ, Subbarao K, Jiang S, Dimitrov DS. Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies. Proc Natl Acad Sci U S A. 2007 Jul 17; 104(29):12123-8. PMID: 17620608.
      Citations: 151     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    46. Roberts A, Lamirande EW, Vogel L, Jackson JP, Paddock CD, Guarner J, Zaki SR, Sheahan T, Baric R, Subbarao K. Animal models and vaccines for SARS-CoV infection. Virus Res. 2008 Apr; 133(1):20-32. PMID: 17499378.
      Citations: 76     Fields:    Translation:HumansAnimalsCells
    47. Chen J, Subbarao K. The Immunobiology of SARS*. Annu Rev Immunol. 2007; 25:443-72. PMID: 17243893.
      Citations: 138     Fields:    Translation:HumansAnimalsCells
    48. Roberts A, Deming D, Paddock CD, Cheng A, Yount B, Vogel L, Herman BD, Sheahan T, Heise M, Genrich GL, Zaki SR, Baric R, Subbarao K. A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice. PLoS Pathog. 2007 Jan; 3(1):e5. PMID: 17222058.
      Citations: 253     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    49. Vogel LN, Roberts A, Paddock CD, Genrich GL, Lamirande EW, Kapadia SU, Rose JK, Zaki SR, Subbarao K. Utility of the aged BALB/c mouse model to demonstrate prevention and control strategies for severe acute respiratory syndrome coronavirus (SARS-CoV). Vaccine. 2007 Mar 08; 25(12):2173-9. PMID: 17227689.
      Citations: 15     Fields:    Translation:AnimalsCellsPHPublic Health
    50. DeDiego ML, Alvarez E, Almazán F, Rejas MT, Lamirande E, Roberts A, Shieh WJ, Zaki SR, Subbarao K, Enjuanes L. A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo. J Virol. 2007 Feb; 81(4):1701-13. PMID: 17108030.
      Citations: 174     Fields:    Translation:HumansAnimalsCells
    51. Gillim-Ross L, Subbarao K. Emerging respiratory viruses: challenges and vaccine strategies. Clin Microbiol Rev. 2006 Oct; 19(4):614-36. PMID: 17041137.
      Citations: 59     Fields:    Translation:HumansAnimalsCells
    52. Kam YW, Kien F, Roberts A, Cheung YC, Lamirande EW, Vogel L, Chu SL, Tse J, Guarner J, Zaki SR, Subbarao K, Peiris M, Nal B, Altmeyer R. Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcgammaRII-dependent entry into B cells in vitro. Vaccine. 2007 Jan 08; 25(4):729-40. PMID: 17049691.
      Citations: 101     Fields:    Translation:AnimalsCells
    53. Roberts A, Wood J, Subbarao K, Ferguson M, Wood D, Cherian T. Animal models and antibody assays for evaluating candidate SARS vaccines: summary of a technical meeting 25-26 August 2005, London, UK. Vaccine. 2006 Nov 30; 24(49-50):7056-65. PMID: 16930781.
      Citations: 9     Fields:    Translation:AnimalsCells
    54. Subbarao K, Roberts A. Is there an ideal animal model for SARS? Trends Microbiol. 2006 Jul; 14(7):299-303. PMID: 16759866.
      Citations: 55     Fields:    Translation:HumansAnimalsCells
    55. Roberts A, Thomas WD, Guarner J, Lamirande EW, Babcock GJ, Greenough TC, Vogel L, Hayes N, Sullivan JL, Zaki S, Subbarao K, Ambrosino DM. Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian hamsters. J Infect Dis. 2006 Mar 01; 193(5):685-92. PMID: 16453264.
      Citations: 47     Fields:    Translation:AnimalsCells
    56. Kapadia SU, Rose JK, Lamirande E, Vogel L, Subbarao K, Roberts A. Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine. Virology. 2005 Sep 30; 340(2):174-82. PMID: 16043204.
      Citations: 94     Fields:    Translation:AnimalsCells
    57. Stadler K, Roberts A, Becker S, Vogel L, Eickmann M, Kolesnikova L, Klenk HD, Murphy B, Rappuoli R, Abrignani S, Subbarao K. SARS vaccine protective in mice. Emerg Infect Dis. 2005 Aug; 11(8):1312-4. PMID: 16110580.
      Citations: 21     Fields:    Translation:AnimalsCellsPHPublic Health
    58. Roberts A, Paddock C, Vogel L, Butler E, Zaki S, Subbarao K. Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans. J Virol. 2005 May; 79(9):5833-8. PMID: 15827197.
      Citations: 111     Fields:    Translation:AnimalsCells
    59. Sui J, Li W, Roberts A, Matthews LJ, Murakami A, Vogel L, Wong SK, Subbarao K, Farzan M, Marasco WA. Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants. J Virol. 2005 May; 79(10):5900-6. PMID: 15857975.
      Citations: 78     Fields:    Translation:HumansAnimalsCells
    60. Bisht H, Roberts A, Vogel L, Subbarao K, Moss B. Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein. Virology. 2005 Apr 10; 334(2):160-5. PMID: 15780866.
      Citations: 42     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    61. Greenough TC, Babcock GJ, Roberts A, Hernandez HJ, Thomas WD, Coccia JA, Graziano RF, Srinivasan M, Lowy I, Finberg RW, Subbarao K, Vogel L, Somasundaran M, Luzuriaga K, Sullivan JL, Ambrosino DM. Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice. J Infect Dis. 2005 Feb 15; 191(4):507-14. PMID: 15655773.
      Citations: 67     Fields:    Translation:AnimalsCells
    62. Roberts A, Vogel L, Guarner J, Hayes N, Murphy B, Zaki S, Subbarao K. Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters. J Virol. 2005 Jan; 79(1):503-11. PMID: 15596843.
      Citations: 128     Fields:    Translation:HumansAnimalsCells
    63. McAuliffe J, Vogel L, Roberts A, Fahle G, Fischer S, Shieh WJ, Butler E, Zaki S, St Claire M, Murphy B, Subbarao K. Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys. Virology. 2004 Dec 05; 330(1):8-15. PMID: 15527829.
      Citations: 106     Fields:    Translation:AnimalsCells
    64. Darnell ME, Subbarao K, Feinstone SM, Taylor DR. Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV. J Virol Methods. 2004 Oct; 121(1):85-91. PMID: 15350737.
      Citations: 205     Fields:    Translation:AnimalsCells
    65. Glass WG, Subbarao K, Murphy B, Murphy PM. Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice. J Immunol. 2004 Sep 15; 173(6):4030-9. PMID: 15356152.
      Citations: 147     Fields:    Translation:AnimalsCells
    66. Prentice E, McAuliffe J, Lu X, Subbarao K, Denison MR. Identification and characterization of severe acute respiratory syndrome coronavirus replicase proteins. J Virol. 2004 Sep; 78(18):9977-86. PMID: 15331731.
      Citations: 146     Fields:    Translation:AnimalsCells
    67. Traggiai E, Becker S, Subbarao K, Kolesnikova L, Uematsu Y, Gismondo MR, Murphy BR, Rappuoli R, Lanzavecchia A. An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat Med. 2004 Aug; 10(8):871-5. PMID: 15247913.
      Citations: 310     Fields:    Translation:HumansAnimalsCells
    68. Bukreyev A, Lamirande EW, Buchholz UJ, Vogel LN, Elkins WR, St Claire M, Murphy BR, Subbarao K, Collins PL. Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS. Lancet. 2004 Jun 26; 363(9427):2122-7. PMID: 15220033.
      Citations: 116     Fields:    Translation:AnimalsCellsPHPublic Health
    69. Buchholz UJ, Bukreyev A, Yang L, Lamirande EW, Murphy BR, Subbarao K, Collins PL. Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity. Proc Natl Acad Sci U S A. 2004 Jun 29; 101(26):9804-9. PMID: 15210961.
      Citations: 183     Fields:    Translation:AnimalsCellsPHPublic Health
    70. Yang ZY, Huang Y, Ganesh L, Leung K, Kong WP, Schwartz O, Subbarao K, Nabel GJ. pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN. J Virol. 2004 Jun; 78(11):5642-50. PMID: 15140961.
      Citations: 243     Fields:    Translation:HumansAnimalsCells
    71. Bisht H, Roberts A, Vogel L, Bukreyev A, Collins PL, Murphy BR, Subbarao K, Moss B. Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. Proc Natl Acad Sci U S A. 2004 Apr 27; 101(17):6641-6. PMID: 15096611.
      Citations: 180     Fields:    Translation:HumansAnimalsCells
    72. Subbarao K, McAuliffe J, Vogel L, Fahle G, Fischer S, Tatti K, Packard M, Shieh WJ, Zaki S, Murphy B. Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice. J Virol. 2004 Apr; 78(7):3572-7. PMID: 15016880.
      Citations: 200     Fields:    Translation:AnimalsCells
    73. Yang ZY, Kong WP, Huang Y, Roberts A, Murphy BR, Subbarao K, Nabel GJ. A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. Nature. 2004 Apr 01; 428(6982):561-4. PMID: 15024391.
      Citations: 295     Fields:    Translation:AnimalsCellsPHPublic Health
    Subbarao's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (369)
    Explore
    _
    Co-Authors (450)
    Explore
    _
    Similar People (60)
    Explore
    _